Eligard® 45 mg


Powder and solvent for solution for injection
scheduling status
S4
registration number
A39/26/0651
What Eligard® 45 mg contains
45 mg leuprorelin acetate, equivalent to 41,7 mg leuprorelin.
other ingredients
Solvent (Syringe A): Poly (DL-lactic-co-glycolic-acid); N-Methylpyrrolidone.
Therapeutic classification
L02A E02.
© 2026 SAHPRA. ALL RIGHTS RESERVED